The Maharashtra government on Friday capped the charges for treatment of mucormycosis patients at private hospitals in the state, where the official number of such cases has gone above 5,000.
The Bombay High Court on Thursday said that Maharashtra needs to tell the Centre that mucormycosis patients in the Marathwada region of the state are dying due to the shortage of medicine required in its treatment. Justices R V Ghuge and B U Debadwar of the high court's Aurangabad bench was informedthat patients in Marathwada were being under-treated as there is a shortage in the supply of Amphotericin B, a drug used in the treatment of mucormycosis or black fungus infection. The bench was hearing petitions pertaining to the COVID-19 pandemic. Advocate Satyajit Bora, appointed to assist the court, argued that patients are being administered one to two injections per day as against the requirement of four to five injections per patient per day. As a consequence, there have been 124 deaths. Even today, there is a shortage of about 70 per cent of the required quantity of the drug, he said. Government pleader D R Kale told the court that currently there are 1,178 ...
Meanwhile, the country extended the lockdown in the Kathmandu Valley till June 14 due to the spike in COVID-19 cases.
Of the 1,250 affected patients, 1,193 are still under treatment.
He said an additional 1,930 vials of Amphotericin-B has been allocated to Karnataka.
: Researchers at Indian Institute of Technology, Hyderabad, have developed an oral solution to treat Black Fungus (Mucormycosis) and other fungus and are ready to transfer the technology to take it forward, the premier institute said.
About 600 cases of black fungus or mucormycosis have been reported here till May 26
The Delhi High Court Thursday allowed duty free import of Amphotericin B
Black fungus cases are on the rise in India
Gujarat and Maharashtra currently lead in Mucormycosis infections in the country with 2,859 and 2,770 cases respectively.
The West Bengal government has declared mucormycosis or black fungus as a 'notifiable disease' considering the gravity of the situation and following the advice of the union health ministry
Delhi Lieutenant Governor Anil Baijal on Monday asked officials to undertake a real-time assessment and review of the requirement of drugs needed for the treatment of black fungus in city hospitals and ensure their "immediate procurement", sources said. He also directed officials to address any additional and prospective logistical requirements in hospitals with regard to the treatment of black fungus at the earliest, they said. This comes amid a rising number of black fungus or mucormycosis cases in Delhi. According to Chief Minister Arvind Kejriwal, as of Monday, Delhi has around 500 mucormycosis cases and the city has been grappling with a shortage of Amphotericin-B injection used in the treatment of the fungal infection. The LG asked officials to undertake a "real-time assessment and review of the requirement of drugs" needed for the treatment of black fungus in Delhi hospitals and ensure their "immediate procurement", the sources said. "Any additional and prospective logistic
AIIMS director Randeep Guleria on Monday said it is better to identify mucormycosis by its name rather than by the colour as labelling the same fungus with names of different colors can create confusion. Addressing a press conference by the Union health ministry, he clarified that no definite link of mucormycosis has been seen with oxygen therapy. Many patients taking treatment at home, who were not on oxygen therapy, have also been found to get infected with mucormycosis. So there is no definite link between oxygen therapy and catching the infection, he said. Guleria underlined that it is better not to use the term black fungus' while talking about mucormycosis, as it leads to a lot of avoidable confusion. "Labelling the same fungus with names of different colors can create confusion. Mucormycosis is not a communicable disease, unlike COVID-19. About 90-95 per cent of patients getting infected with mucormycosis are found to have been either diabetic and/or taking steroids. This ..
As many as 5,424 cases of mucormycosis or black fungus have been reported from 18 states, with a majority of them in Gujarat and Maharashtra, Union Health Minister Harsh Vardhan said on Monday. Nine lakh vials of Amphotericin-B are being imported by the central government for the treatment of Black Fungus. Of this, 50,000 vials have been received and around three lakh vials will be available in the next seven days," he said. Speaking at the 27th group of ministers (GoM) meeting on COVID-19, he said that Gujarat reported 2165 cases, Maharashtra 1188, Uttar Pradesh 663, Madhya Pradesh 590, Haryana 339 and Andhra Pradesh 248 cases. "Out of these 5,424 cases of mucormycosis, we have seen that 4, 556 cases have a history of COVID-19 infection, while 875 cases are amongst non-COVID patients. Diabetes was present in 55 percent of the patients. "We have been warning, issuing advisories and, through our experts, it has been communicated that indiscriminate use of steroids must be avoided
The city has been grappling with a shortage of Amphotericin-B
Cases of mucormycosis in Covid patients are on the rise in Maharashtra, Gujarat, Delhi and the southern states of India. All you need to know about the black fungus, its symptoms, treatment & more
These samples were taken from Kupta village in Selu tehsil of Parbhani district and from Lokhandi Sawargaon village in Beed district
DeepMind Technologies Ltd.'s AlphaFold reached the threshold for "solving" the problem at the latest Critical Assessment of Structure Prediction competition
The immune system's memory helper T cells also identifies some parts of the novel coronavirus, according to a study whose findings may explain why some people have milder Covid-19 cases than others.
Several teams across the world are in a race to develop a vaccine for coronavirus infection